维普中文期刊产品整合服务
22篇 您的检索式:作者名="STRAVODIMOS K"
    题名 作者 年代 出处 被引量
1Immunohistochemical expression of transforming growth factor beta 1 an d nm-23H1 antioncogene in prostate cancer:, divergent correlation with clinicopathological parameters显示文摘Stravodimos K Constantinides C Manousakas T 2000Anticancer Res2000,20,5:1
2Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens显示文摘Pavlakis K Stravodimos K Kapetanakis T 2010Int Urol Nephrol2010,42,2:1
3Immunohistochemical expression of transforming growth factor beta-1 and nm-23H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters 显示文摘Stravodimos K Constantinides C Manousakas T 2000AnticancerRes2000,20,5:1
4Immunohistochemical expression of transforming growth factor beta 1 and nm-23H1 antioncogene in prostate cancer:divergent correlation with clinicopathological parameters显示文摘Stravodimos K Constantinides C Manousakas T 2000Anticancer Res2000,20,:1
5Implementation and external validation of Preoperative Aspects and Di- mensions Used for an Anatomical (PADUA) score for predicting complications in 74 consecutive partial ne- phrectomies显示文摘Tyritzis S I Papadoukakis S Katafigiotis I Adamakis I Anastasiou I Stravodimos K G 2012BJU Int2012,109,:1
6Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients显示文摘Avgeris M K Stravodimos A Scorilas 2014Biol Chem2014,395,9:1
7Immunohistochemical expression of transfotming growth factor beta 1 and nm-23 H1antioncogene in prostate cancer:divergent correlation with clinicopathological parameters显示文摘STRAVODIMOS K CONSTANTINIDES C MANOUSAKAS T 2000Anticancer Res2000,20,5:1
8The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients 显示文摘Avgeris M Stravodimos K Fragoulis EG 2013Br J Cancer2013,108,12:1
9Prolonged ureteral stenting in obstruction after renal transplantation: long-term results 显示文摘Pappas P Stravodimos K G Adamakis I 2004Transplant Proc2004,36,5:1
10Downregulation and prognostic performance of microRNA 224 expression in prostate cancer显示文摘Mavridis K Stravodimos K Scorilas A 2013Clin Chem2013,59,1:1
11Evaluation of rou- tine application of P504S, 3413E12 and p63 immunostaining on 250 prostate needle biopsy specimens 显示文摘Pavlakis K Stravodimos K Kapetanakis T 2010International Urology and Nephrology2010,42,2:1
12Immuno-histochemical expression of tran-sforming growth factor betal and nm-23H1 antioncogene in prostate cancer:divergent correlation with clinicopathological parameters显示文摘Stravodimos K Constantinides C Manousakas T 0,,5:1
13Hydronephrosis promotes expression of hypoxia-inducible factor 1 alpha显示文摘STRAVODIMOS K G KORITSIADIS G LAZARIS A C 2009Urol Int2009,82,1:1
14Evaluation of routine application of P504S,34betaE12 and p63 imrnunostaining on 250 prostate needle biopsy specimens 显示文摘Pavlakis K Stravodimos K Kapetanakis T 2010tnt Urol Nephrol2010,42,2:1
15Androgens and bladder outlet obstruction: a correlation with pressure-flowvariables in a preliminary study 显示文摘Koritsiadis G Stravodimos K Mitropoulos D 2008BJU Int2008,101,12:1
16Evalua tion of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens 显示文摘Pavlakis K Stravodimos K Kapetanakis T 2010Int Urol Nephrol2010,42,2:1
17Downregulation and prognostic performance of microRNA 224 expression in prostate cancer显示文摘Mavridis K Stravodimos K Scorilas A 2013Clin Chem2013,59,1:1
18Evaluation of routine application of P504S,34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens 显示文摘Pavlakis K Stravodimos K Kapetanakis T 2010Int Urol Nephrol2010,42,2:1
19Spon- taneous perforation of the ureter: clinical presentation and endourologie management 显示文摘Stravodimos K Adamakis I Koutalellis G 2008J Fndourol2008,22,3:1
20Spontaneous perforation of the ureter: clinical presentation and endourologic management显示文摘STRAVODIMOS K ADAMAKIS I KOUTALELLIS G 2008J Endourol2008,22,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费